Heart failure affects nearly 6 million Americans, but a new study on a tiny medical device, Abbott’s MitraClip, is giving patients and their families hope. Dr. Paul Sorajja, Roger L. and Lynn C. Headrick Family Chair for Valve Science Research at the MHIF Valve Science Center, was interviewed this week by Rena Sarigianopoulos on KARE 11 News about the latest advances in the treatment of mitral regurgitation.
Results from the COAPT trial, announced at TCT 2018 in San Diego last month, showed that treatment of mitral regurgitation with MitraClip not only improved symptoms, but it saved lives and kept patients out of the hospital. The study showed survival rate improved by 40%. Minneapolis Heart Institute Foundation was a participating clinical site for this study.
Sorajja said, “The results have just been miraculous…”
A challenge of heart failure or leaky valves is that people might not even know they have it. Symptoms include shortness of breath, swelling in legs and/or fatigue. These symptoms can resemble lung disease; it’s hard to distinguish. But these symptoms can signify something life-threatening, so seek care! Talk to your doctor if you’re experiencing any symptoms.